Scribd Logo
Upload

Welcome to Scribd!

  • Mapping PPLK Lt. 3 Senin, 18 Maret 2024

    Uploaded by

    PPDS Geriatri IPD UA
    10 views1 page
    1. There are 6 patients currently hospitalized out of 17 beds (35% occupancy). 1 patient is in class 1, 1 in class 2, and 4 in class 3. The average length of stay is 4.3 days. 2. The document provides details on the primary problems, additional diagnoses, related divisions, non-IPD related issues, additional problems, and length of stay for each patient. 3. Patients are being treated for issues like ALL, Ewing sarcoma, AML, lymphoma, breast cancer, colorectal cancer, and more. Treatments include chemotherapy, re-induction, and more. Complications reported include anemia, thrombocytopenia, and none for

    Original Description:

    Napkin

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    1. There are 6 patients currently hospitalized out of 17 beds (35% occupancy). 1 patient is in class 1, 1 in class 2, and 4 in class 3. The average length of stay is 4.3 days. 2. The document provides details on the primary problems, additional diagnoses, related divisions, non-IPD related issues, additional problems, and length of stay for each patient. 3. Patients are being treated for issues like ALL, Ewing sarcoma, AML, lymphoma, breast cancer, colorectal cancer, and more. Treatments include chemotherapy, re-induction, and more. Complications reported include anemia, thrombocytopenia, and none for

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    10 views1 page

    Mapping PPLK Lt. 3 Senin, 18 Maret 2024

    Uploaded by

    PPDS Geriatri IPD UA
    1. There are 6 patients currently hospitalized out of 17 beds (35% occupancy). 1 patient is in class 1, 1 in class 2, and 4 in class 3. The average length of stay is 4.3 days. 2. The document provides details on the primary problems, additional diagnoses, related divisions, non-IPD related issues, additional problems, and length of stay for each patient. 3. Patients are being treated for issues like ALL, Ewing sarcoma, AML, lymphoma, breast cancer, colorectal cancer, and more. Treatments include chemotherapy, re-induction, and more. Complications reported include anemia, thrombocytopenia, and none for

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    LAPORAN PASIEN YANG MASIH DIRAWAT

    PPLK
    Senin, 18 Maret 2024
    BOR Total: 6 / 17 (35%)
    Kelas 1: 1 / 2
    Kelas 2: 1 / 4
    Kelas 3: 4 / 11
    Average LOS = 4.3 hari
    Divisi yang berkaitan masalah lain KSM non-IPD yang berkaitan
    DPJP Asisten DPJP Masalah tambahan Lama perawatan
    (Dx penyerta/tambahan/komorbid) (Dx penyerta/tambahan/komorbid)
    – DPJP Utama – PPDS Masalah utama (Divisi)
    Nama pasien Mandiri (Gejala/kondisi →
    Bed – DPJPK Keterangan
    (inisial) – PPDS Masalah lain Masalah lain Masalah lain Masalah lain Masalah lain Masalah lain problem solving
    (Divisi) Keterangan: Menjadi Dx utama < 2 hari 2-5 hari 6-10 hari 11-14 hari > 14 hari
    Magang (Divisi) (Divisi) (Divisi) (KSM) (KSM) (KSM) atau komplikasi →
    – DPJPK – PPDS severity of disease)
    (non-IPD) Pengayaan
    Prof. Dr. dr. ALL L1 belum remisi post VP 12x dan VDP 10x (terakhir
    Ny. Reni Nur Safitri / Ugroseno Yudho 26/1/24) pro VDP-12 Anemia
    1.1 dr. Andreas 5 hari
    24 th / 12960631 Bintoro, Sp.PD, Anemia normorkromik-normositer (Hb 6.1 > 9.3) Trombositopenia
    K-HOM Trombositopenia (PLT 45.000 > 71.000)
    1.2

    Prof. Dr. dr.


    Nn. Riris Octavia Marta Ugroseno Yudho Ekstraskeletal Ewing Sarcoma cruris sinistra post wide
    2.1 dr. Andreas - 3 hari
    / 29 th / 13017244 Bintoro, Sp.PD, reseksi pro Kemoterapi IE siklus ke-5
    K-HOM
    2.2
    2.3
    2.4

    3.1.P
    3.2.P
    Prof. Dr. dr.
    AML M4 post A5D3 dan A7D3 pro kemoterapi
    Nn. Anggi Anggita / 20 Ugroseno Yudho
    3.3 P dr. Andreas re-induksi pro A5D2 D-5 Trombositopenia 9 hari
    th / 13030529 Bintoro, Sp.PD,
    Trombositopenia (34.000 > 83.000 > 43.000 > 38.000)
    K-HOM
    3.4 P

    Prof. Dr. dr.


    Tn. Lugianto / 64 th / Ugroseno Yudho Diffuse large B cell Lymphoma regio colli S et axilla D/S,
    3.1.L dr. Andreas - 3 hari
    13019345 Bintoro, Sp.PD, CD20+, post RCHOP VI PR, pro CEOP III
    K-HOM
    3.2 L
    3.3 L
    3.4 L
    Prof. Dr. dr. Tumor mamma S klinis ganas T4cN2M1 (Paru,
    Ny. Kundawati / 49 th / Ugroseno Yudho Vertebra, susp KGB kontralateral) post kemoterapi
    3.5 L dr. Andreas Anemia 3 hari
    13040732 Bintoro, Sp.PD, Carbo-Pacli V (25/2/24) pro Carbo-Pacli VI
    K-HOM Anemia (Hb 8 > 11.7)
    Prof. Dr. dr.
    Tn. Wiji Purwanto / 48 Ugroseno Yudho Ca Rectosigmoid on Stoma T3bN2M1a (Stadium IIIc)
    3.6 L dr. Andreas - 3 hari
    th / 13044532 Bintoro, Sp.PD, adenocarcinoma pro FOLFOX IIB
    K-HOM
    3.7 L
    EB

    You might also like